TY - JOUR
T1 - Mapping of a second actin-tropomyosin and a second troponin C binding site within the C terminus of troponin I, and their importance in the Ca2+-dependent regulation of muscle contraction
AU - Tripet, Brian
AU - Van Eyk, Jennifer E.
AU - Hodges, Robert S.
N1 - Funding Information:
We thank Paul Semchuck for technical assistance with peptide synthesis, Morris Aarbo for technical assistance in the isolation and purification of the muscle proteins, Dr L. B. Smillie’s laboratory (University of Alberta, Edmonton) for laboratory resources, Lorne Burke for assistance with the Figures, and Dr C. T. Mant for helpful discussions and comments on the preparation of the manuscript. This research was supported by the Medical Research Council of Canada and a studentship (B.T.) from the Alberta Heritage Foundation for Medical Research, Alberta, Canada.
Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 1997/9/5
Y1 - 1997/9/5
N2 - To investigate the functional importance of the C-terminal residues 116 to 148 of troponin I (TnI) in the Ca2+-dependent regulation of vertebrate skeletal muscle contraction, we have prepared several synthetic TnI peptide analogs corresponding to various regions within residues 96 to 148 of rabbit skeletal TnI, and analyzed each of these peptides in reconstituted thin filament assays. Our results show that the TnI peptide 96 to 148 (TnI96-148) constitutes the minimal sequence of TnI capable of mediating an inhibitory activity similar to that of intact TnI protein. Truncation of residues 140 to 148 from this region (TnI96-139) or substitution of residues K141, K142 and K144 with alanine (TnI(96-148A2)) completely abolishes the enhanced inhibitory effect of this region when compared with TnI96-115. A synthetic peptide, residues 128 to 148 of TnI, containing residues 140 to 148 , now termed the 'second actin-tropomyosin (actin-Tm) binding site' is able to bind specifically to the actin-Tm filament and can induce a weak inhibitory activity on its own. Residues 116 to 131 of TnI do not appear to be important for inhibition, but are critical for interacting with troponin C (TnC). Specific investigations into this region have shown that residues 116 to 126, located directly adjacent to the 'inhibitory region' (residues 96 to 115), are critical for allowing TnC to neutralize fully and rapidly the acto-S1-Tm inhibition caused by the various TnI Peptides. Furthermore, residues 116 to 131 of TnI, now termed the 'second TnC binding site', can significantly enhance the binding affinity of the inhibitory region, residues 96 to 115, for TnC in a Ca2+-dependent manner as determined by affinity chromatography analysis. The implication that TnI residues 116 to 131 bind to the N domain of TnC, and thus the inhibitory region (residues 96 to 115) binds to the C domain of TnC, has made us re-investigate the structural/functional role of the NH2-terminal region of TnI. Studies of competition between the N terminus of TnI (Rp1-40, residues 1 to 40) with the C-terminal peptides TnI96-115 TnI96-139 and TnI96-148 showed that only TnI96-115 could be easily displaced from TnC. These results thus suggest that Ca2+ binding to the regulatory sites of TnC (N domain) altars the binding affinity between the NH2 terminus and the C terminus of TnI for TnC, i.e. a Ca2+-dependent switch between these two sites of TnI for the C domain of TnC. These results have been incorporated into a general model describing the Ca2+-dependent regulation of muscle contraction.
AB - To investigate the functional importance of the C-terminal residues 116 to 148 of troponin I (TnI) in the Ca2+-dependent regulation of vertebrate skeletal muscle contraction, we have prepared several synthetic TnI peptide analogs corresponding to various regions within residues 96 to 148 of rabbit skeletal TnI, and analyzed each of these peptides in reconstituted thin filament assays. Our results show that the TnI peptide 96 to 148 (TnI96-148) constitutes the minimal sequence of TnI capable of mediating an inhibitory activity similar to that of intact TnI protein. Truncation of residues 140 to 148 from this region (TnI96-139) or substitution of residues K141, K142 and K144 with alanine (TnI(96-148A2)) completely abolishes the enhanced inhibitory effect of this region when compared with TnI96-115. A synthetic peptide, residues 128 to 148 of TnI, containing residues 140 to 148 , now termed the 'second actin-tropomyosin (actin-Tm) binding site' is able to bind specifically to the actin-Tm filament and can induce a weak inhibitory activity on its own. Residues 116 to 131 of TnI do not appear to be important for inhibition, but are critical for interacting with troponin C (TnC). Specific investigations into this region have shown that residues 116 to 126, located directly adjacent to the 'inhibitory region' (residues 96 to 115), are critical for allowing TnC to neutralize fully and rapidly the acto-S1-Tm inhibition caused by the various TnI Peptides. Furthermore, residues 116 to 131 of TnI, now termed the 'second TnC binding site', can significantly enhance the binding affinity of the inhibitory region, residues 96 to 115, for TnC in a Ca2+-dependent manner as determined by affinity chromatography analysis. The implication that TnI residues 116 to 131 bind to the N domain of TnC, and thus the inhibitory region (residues 96 to 115) binds to the C domain of TnC, has made us re-investigate the structural/functional role of the NH2-terminal region of TnI. Studies of competition between the N terminus of TnI (Rp1-40, residues 1 to 40) with the C-terminal peptides TnI96-115 TnI96-139 and TnI96-148 showed that only TnI96-115 could be easily displaced from TnC. These results thus suggest that Ca2+ binding to the regulatory sites of TnC (N domain) altars the binding affinity between the NH2 terminus and the C terminus of TnI for TnC, i.e. a Ca2+-dependent switch between these two sites of TnI for the C domain of TnC. These results have been incorporated into a general model describing the Ca2+-dependent regulation of muscle contraction.
KW - Muscle regulation
KW - TnI C terminus
KW - TnI inhibition and release
KW - Troponin C
KW - Troponin I
UR - http://www.scopus.com/inward/record.url?scp=0031554903&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0031554903&partnerID=8YFLogxK
U2 - 10.1006/jmbi.1997.1200
DO - 10.1006/jmbi.1997.1200
M3 - Article
C2 - 9299323
AN - SCOPUS:0031554903
SN - 0022-2836
VL - 271
SP - 728
EP - 750
JO - Journal of molecular biology
JF - Journal of molecular biology
IS - 5
ER -